Short-term primary and revision modular dual-mobility cup total hip arthroplasty outcomes in high-risk dislocation

Martta Ruusiala1, Hannu Miettinen2, Jukka Kettunen2

  • 1Faculty of Health Sciences, University of Eastern Finland, Yliopistonranta 1, 70210, Kuopio, Finland.

Insights

Modular dual-mobility cups (MDMCs) show excellent short-term survival in primary total hip arthroplasty (THA) and moderate survival in revision THA. MDMC use in hip fracture patients significantly reduced dislocation rates.

Area of Science:

  • Orthopedic Surgery
  • Biomaterials Science
  • Arthroplasty Research

Background:

  • Modular dual-mobility cups (MDMCs) are increasingly used in total hip arthroplasty (THA) to mitigate dislocation risk.
  • Assessing the performance of MDMCs in diverse patient populations, including hip fracture cases and revision surgeries, is crucial for optimizing outcomes.

Purpose of the Study:

  • To evaluate implant survivorship, complication rates (especially dislocation), and revision rates for primary and revision THAs utilizing MDMCs.
  • To assess mortality associated with MDMC surgery.
  • To determine if the introduction of MDMCs at Kuopio University Hospital impacted the institutional dislocation rate.

Main Methods:

  • A retrospective cohort study of 101 patients who underwent MDMC implantation between April 2018 and June 2020.
  • Minimum 2-year follow-up to assess implant survival, complications, and mortality.
  • Utilized the Finnish Hospital Discharge Register to analyze yearly THA dislocation rates before and after MDMC implementation.

Main Results:

  • Two-year cumulative implant survival was 97% for primary THA and 90% for revision THA.
  • Dislocation occurred in 1.4% of primary THA and 12.9% of revision THA cases.
  • Two-year cumulative mortality was 13% in both primary and revision THA groups.
  • Post-MDMC implementation, re-hospitalizations due to THA dislocation decreased by 46%.

Conclusions:

  • MDMCs demonstrate excellent short-term survival and low complication rates in primary THA, with moderate outcomes in revision THA.
  • The adoption of MDMC THA for hip fracture patients appears effective in reducing dislocation rates within a short follow-up period.
Abstract

Related Concept Videos